Repligen Corp financial data

Symbol
RGEN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
41 Seyon Street, Building 1, Suite 100, Waltham, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 758 % +149%
Quick Ratio 121 % +81%
Debt-to-equity 43.3 % +28.6%
Return On Equity -1.29 % -171%
Return On Assets -0.9 % -166%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 56.1M shares +0.49%
Common Stock, Shares, Outstanding 56.1M shares +0.58%
Entity Public Float 5.98B USD -13.7%
Common Stock, Value, Issued 561K USD +0.54%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 43.2M USD +1.12%
Costs and Expenses 670M USD +14.5%
Operating Income (Loss) -35.1M USD -174%
Nonoperating Income (Expense) 8.08M USD -10.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -27M USD -148%
Income Tax Expense (Benefit) -1.52M USD -107%
Net Income (Loss) Attributable to Parent -25.5M USD -172%
Earnings Per Share, Basic -0.46 USD/shares -172%
Earnings Per Share, Diluted -0.46 USD/shares -173%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 757M USD +0.8%
Accounts Receivable, after Allowance for Credit Loss, Current 134M USD +8.02%
Inventory, Net 143M USD -29.3%
Other Assets, Current 12.1M USD -8.93%
Assets, Current 1.07B USD -4.08%
Deferred Income Tax Assets, Net 749K USD -51%
Property, Plant and Equipment, Net 198M USD -4.68%
Operating Lease, Right-of-Use Asset 135M USD +17.2%
Intangible Assets, Net (Excluding Goodwill) 398M USD -2.23%
Goodwill 1.03B USD +4.45%
Other Assets, Noncurrent 868K USD -32%
Assets 2.83B USD -0.05%
Accounts Payable, Current 32.1M USD +64.3%
Employee-related Liabilities, Current 32.2M USD +93.1%
Accrued Liabilities, Current 62.4M USD +8.92%
Liabilities, Current 127M USD -23.1%
Operating Lease, Liability, Noncurrent 146M USD +15%
Other Liabilities, Noncurrent 16.6M USD +47%
Liabilities 857M USD -1.08%
Accumulated Other Comprehensive Income (Loss), Net of Tax -52.5M USD -38.9%
Retained Earnings (Accumulated Deficit) 407M USD -5.89%
Stockholders' Equity Attributable to Parent 1.97B USD +0.4%
Liabilities and Equity 2.83B USD -0.05%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 44.7M USD +301%
Net Cash Provided by (Used in) Financing Activities -8.97M USD +6.16%
Net Cash Provided by (Used in) Investing Activities -8.36M USD +11.4%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 56.1M shares +0.58%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 29.3M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 757M USD +0.8%
Deferred Tax Assets, Valuation Allowance 517K USD +2485%
Deferred Tax Assets, Gross 106M USD +26.6%
Operating Lease, Liability 161M USD +21.5%
Payments to Acquire Property, Plant, and Equipment 8.35M USD -1.92%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -40.2M USD -225%
Lessee, Operating Lease, Liability, to be Paid 196M USD -2.92%
Property, Plant and Equipment, Gross 360M USD +7.15%
Operating Lease, Liability, Current 15.1M USD +168%
Lessee, Operating Lease, Liability, to be Paid, Year Two 27.3M USD +6.42%
Lessee, Operating Lease, Liability, to be Paid, Year One 24.5M USD +8.61%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) -1.12M USD -42.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 32.1M USD -1.65%
Lessee, Operating Lease, Liability, to be Paid, Year Three 25.9M USD +1.76%
Deferred Tax Assets, Operating Loss Carryforwards 9.88M USD +29.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 2.13M USD -32.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 26.1M USD +8.81%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 34.7M USD +9.81%
Deferred Tax Assets, Net of Valuation Allowance 106M USD +26%
Interest Expense 11.3M USD +887%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%